| Literature DB >> 32777940 |
Scott Sherrill-Mix1, Kaleigh Connors2, Grace M Aldrovandi3, Jason M Brenchley4, Charles Boucher5, Frederic D Bushman1, Ronald G Collman6, Satya Dandekar7, Nichole R Klatt8, Laurel A Lagenaur9, Roger Paredes10, Gilda Tachedjian11, Jim A Turpin12, Alan L Landay13, Mimi Ghosh2.
Abstract
In October of 2019, researchers and community members from around the world met at the NIH for the fifth annual International Workshop on Microbiome in HIV. New research was presented on the role of the microbiome on chronic inflammation and vaccine design, interactions of genetics, environment, sexual practice and HIV infection with the microbiome and the development and clinical trials of microbiome-based therapeutic approaches intended to decrease the probability of HIV acquisition/transmission or ameliorate sequelae of HIV. The keynote address by Dr. Jacques Ravel focused on his work on the vaginal microbiome and efforts to improve the analysis and resolution of microbiome data.Entities:
Keywords: HIV/SIV; comorbidities; microbiome; pathogenesis; therapeutics; transmission
Year: 2020 PMID: 32777940 PMCID: PMC7869876 DOI: 10.1089/AID.2020.0121
Source DB: PubMed Journal: AIDS Res Hum Retroviruses ISSN: 0889-2229 Impact factor: 2.205